Marx, Nikolaus <br/><br/>
PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.  [electronic resource] 

 -  Circulation research  Apr 2002 
 - 703-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/01.res.0000014225.20727.8f  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--immunology<br/>Arteriosclerosis--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cells, Cultured<br/>Fenofibrate--pharmacology<br/>Graft Survival--immunology<br/>Heart Transplantation<br/>Humans<br/>Interferon-gamma--immunology<br/>Interleukin-2--immunology<br/>Lymphocyte Activation--drug effects<br/>Peroxisome Proliferators--pharmacology<br/>Pioglitazone<br/>Pyrimidines--pharmacology<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Rosiglitazone<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Transcription Factors--agonists<br/>Tumor Necrosis Factor-alpha--immunology